Imeglimin hydrochloride is an oral anti-diabetic medication approved for use in Japan. It is an active pharmaceutical ingredient used in the manufacturing of pharmaceutical products.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing Imeglimin (hydrochloride)?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.
Kenalog
pharmaceutical raw material
Delafloxacin meglumine
pharmaceutical raw material
10-Gly-LHRH
pharmaceutical raw material
Risedronate sodium monohydrate
pharmaceutical raw material
Imeglimin hydrochloride
pharmaceutical raw material
Imeglimin
pharmaceutical raw material
6-N,6-N,4-trimethyl-1,4-dihydro-1,3,5-triazine-2,6-diamine;hydrochloride
UXHLCYMTNMEXKZ-UHFFFAOYSA-N
CC1N=C(NC(=N1)N(C)C)N.Cl
Sourcing Imeglimin (hydrochloride)?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.